THE Australian Medical
Association has moved to assure
Australians in the wake of concerns
over the disparity between the US
Advisory Committee on
Immunisation Practices and the
advice from the Chief Medical
Officer in Australia the use of CSL’s
seasonal influenza vaccine Fluvax
in children.
The AMA said that whilst there
are differences in advice from US
officials on the blanket vaccination
of children and Australia’s at-risk
program, there has been no new
concerns raised in Australia by the
Chief Medical Officer “despite
close vigilance”.
In addition, the AMA has thrown
its support behind the CMO’s
reccomendation that kids aged
between six-months and five years
should be vaccinated with Vaxigrip
and Influvac, and that children in
this age group should not be given
Fluvax or Fluvax Junior due to
increased risk of febrile convulsions.The above article was sent to subscribers in Pharmacy Daily's issue from 23 Aug 10 To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 23 Aug 10
IN WESTERN Australia, Michael’s Chemist Group has started stocking therapeutic Nicotine Vaping Products (NVPs), pursuant to the Federal Government’s new vaping laws (PD 25 Mar).
FREE Pharmacy Daily subscription - never miss another story!
to top
Subscribe to Pharmacy Daily
Pharmacy Daily subscription confirmation
Thank you for signing up! Check your email inbox – you should shortly receive a message with a link which must be clicked to confirm your subscription.
Once you’ve done that you will begin receiving Pharmacy Daily as soon as the next issue is published.